Stockscreener 앱 받기
2.375
9.00%
-0.235
Insight Molecular Diagnostics Inc 주식(IMDX)의 최신 뉴스
Needham reiterates Buy rating on Insight Molecular Diagnostics stock - Investing.com
Insight Molecular Diagnostics Reports Q2 2025 Progress - TipRanks
Insight Molecular Diagnostics: Q2 Earnings Snapshot - San Francisco Chronicle
Earnings call transcript: Insight Molecular Diagnostics Q2 2025 reveals strategic advancements - Investing.com
IMDX Reports Q2 2025 Results and Momentum Toward GraftAssureDx Launch - GlobeNewswire
IMDX Earnings: Major Breakthrough in $1B Transplant Testing Market as Mayo Clinic, Cleveland Clinic Join Trial - Stock Titan
Insight Molecular Diagnostics Inc expected to post a loss of 23 cents a shareEarnings Preview - TradingView
Insight Molecular Diagnostics Inc.Common Stock (Nasdaq:IMDX) Stock Quote - FinancialContent
Molecular Diagnostics Market Overview: Growth Factors to 2035 - MarketReports.us
PCR Molecular Diagnostics Market Global Forecast 2025–2032: Sector-Wise Insights - newstrail.com
Insight Molecular Diagnostics Inc. shares rise 8.81% premarket after QIAGEN's solid Q2 2025 results. - AInvest
iMDx to Release Second Quarter 2025 Results on August 11, 2025 and Attend Needham Virtual MedTech and Diagnostics Conference - The Manila Times
iMDx to Release Second Quarter 2025 Results on August 11, - GlobeNewswire
iMDx Announces Two Major Investor Events: Q2 Earnings and Needham Conference Back-to-Back - Stock Titan
Diagnostic Contract Manufacturing Market Forecast 2025–2034: Key Metrics and Strategic Insights - WhaTech
IMDX World Transplant Congress Late-Breaking Data - GlobeNewswire
IMDX World Transplant Congress Late-Breaking Data Potentially Sets New Bar for Predicting Graft Rejection in Kidney Transplant Patients - Yahoo Finance
U.S., Europe, and Asia Pacific Molecular Diagnostics Market - openPR.com
iMDx to Host Virtual KOL Event to Discuss its In-House - GlobeNewswire
Vanderbilt Professor Reveals Game-Changing In-House Kidney Transplant Testing Technology at Expert Event - Stock Titan
Analysts Are Bullish on Top Healthcare Stocks: ProMIS Neurosciences (PMN), Bruker (BRKR) - The Globe and Mail
Insight Molecular Diagnostics Inc. shares fall 3.16% intraday as ImmunoPrecise Antibodies Ltd. announces new findings. - AInvest
Insight Molecular Diagnostics Inc. shares rise 5.32% premarket after Seegene unveils new diagnostic system and data analytics platform. - AInvest
Insight Molecular Diagnostics Insiders Increase Holdings Amidst Bullish Bets - AInvest
Insight Molecular Diagnostics Insiders Placed Bullish Bets Worth US$2.82m - Yahoo Finance
U.S. In Vitro Diagnostics (IVD) Market and Competition - GlobeNewswire
U.S. In Vitro Diagnostics (IVD) Market and Competition Insights 2025-2034Next-Gen Genomic Tools and Decentralized Testing to Transform U.S. Diagnostics Landscape - Yahoo.co
Clinical Laboratory Services Market Expanding with Diagnostic Testing Growth and Automation Advancements - newstrail.com
Sepsis Diagnostics Market: Global Industry Overview, Trends, Challenges, and Regional Insights - PharmiWeb.com
Insight Molecular Diagnostics Inc. shares rise 1.24% intraday after Agilent Technologies and Oxford BioDynamics host webinar on 3D genomic biomarker discovery. - AInvest
Proteinase K Market Grows Amid Rising Demand for Molecular Research and Diagnostics - newstrail.com
Companion Diagnostic Technologies Market Watch: Strategic Forecasts Amid Rising Economic Volatility - newstrail.com
IVD Contract Manufacturing Services Market Watch: Strategic Forecasts Amid Rising Economic Volatility - newstrail.com
Molecular Diagnostics Market Future Business Opportunities 2025-2032 | USD 27.8 billion by 2032, CAGR of 9.1% - newstrail.com
3 Medical Info Systems Stocks to Buy Amid AI Boom and Tariff Risk - TradingView
Molecular Diagnostics Market Booming as Precision Medicine, - openPR.com
Liver Cancer Diagnostics Market Analysis 2025–2035 | Trends, Technologies & Regional Insights - PharmiWeb.com
Molecular Diagnostics Reagent Market Driven by Rising Infectious Diseases and Genetic Testing - openPR.com
Oncocyte Relocates HQ from Irvine to Nashville - Orange County Business Journal
Insight Molecular Diagnostics Approves Key Proposals at Annual Meeting - TipRanks
Seegene Launches STAgora™, a New Platform for Infectious Disease Analytics - PR Newswire
Insight Molecular Diagnostics Inc.(NasdaqCM:IMDX) dropped from Russell 3000E Growth Index - MarketScreener
Revolutionizing Healthcare: Molecular Diagnostics Market Set - openPR.com
What's Driving the Future of the Molecular Cytogenetics Market? - openPR.com
Early cancer detection company opening U.S. headquarters in Franklin - Nashville Post
Oncology Molecular Diagnostics Market in Flux: Recession Signals, Tariff Pressures & Strategic Forecasts - newstrail.com
We're Keeping An Eye On Insight Molecular Diagnostics' (NASDAQ:IMDX) Cash Burn Rate - Yahoo Finance
iMDx Reports Strong Head-to-Head Data in Kidney Transplant Rejection Testing - GlobeNewswire
Why Did Insight Molecular Plunge 12.28%? - AInvest
IMDXINSIGHT MOLECULAR DIAGNOSTICS INC Latest Stock News & Market Updates - Stock Titan
Insight Molecular Diagnostics Rebrands and Relocates Headquarters: A Strategic Pivot towards Transplant Medicine - AInvest
Oncocyte Changes Name to Insight Molecular Diagnostics, Relocates HQ to Nashville - MarketScreener
Oncocyte Renamed Insight Molecular Diagnostics, Moves HQ to Nashville. - AInvest
Molecular Diagnostics for Cancer Market Forecasts to 2030 with Executive and Consultant GuidesResearchAndMarkets.com - FinancialContent
OncoCyte Rebrands to Insight Molecular Diagnostics - TipRanks
Point-of-Care Molecular Diagnostics Market Future Business - openPR.com
Bone Marrow Vacuolization at the Crossroads of Specialties: Molecular Insights and Diagnostic Challenges - Wiley Online Library
1.37%
0.60%
자본화:
|
볼륨(24시간):